APC0576, a novel inhibitor of NF-κB-dependent gene activation, prevents pro-inflammatory cytokine-induced chemokine production in human endothelial cells

This publication has 34 references indexed in Scilit:

• NF-κB: a key role in inflammatory diseases
  Journal of Clinical Investigation, 2001
• NF-κB as a therapeutic target in chronic inflammation: recent advances
  Molecular Medicine Today, 2000
• Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway
  Oncogene, 1999
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
  Annual Review of Immunology, 1998
• Cytokine regulation of endothelial cell function: from molecular level to the bedside
  Immunology Today, 1997
• Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
  New England Journal of Medicine, 1997
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• ENDOTHELIAL-DEPENDENT MECHANISMS IN CHRONIC INFLAMMATORY LEUKOCYTE RECRUITMENT
  Annual Review of Medicine, 1996
• Endothelial‐Dependent Mechanisms of Leukocyte Adhesion in Inflammation and Atherosclerosis^a
  Annals of the New York Academy of Sciences, 1990